Warty Dyskeratoma Clinical Presentation
- Author: Molly Ann Allen Hinshaw, MD; Chief Editor: Dirk M Elston, MD more...
Warty dyskeratoma (WD) commonly presents as an asymptomatic keratotic nodule. Scalp, face, and neck are common sites of involvement. Mucosal lesions have been reported.[2, 3, 4] Multiple lesions in the same patient have been reported.[5, 6] Patients may report an insidious onset or a slight recent enlargement of the lesion.
Warty dyskeratoma (WD) presents as a whitish or grayish hyperkeratotic papule with an umbilicated center, often involving the face, scalp, or back. Lesions are usually smaller than 1-2 cm.
Rarely, lesions with a similar appearance can be found involving the mucosal surfaces.[2, 3, 4] Infrequently, subungual warty dyskeratoma occurs and when it does it produces longitudinal erythronychia.[11, 12] Multiple lesions may occur in exceptional cases.[5, 6]
James Fitzpatrick, MD, of Dermatopathology Consultants of Colorado, has demonstrated using immunihistochemistry (unpublished work) that warty dyskeratoma demonstrates absence of SERCA2. This finding suggests that acquired genetic mutations in ATP2A2, as demonstrated by the absence of its protein product, SERCA2, play a role in the development of WD. See the image below.
To date, genetic evaluations of WD for mutations in ATP2A2 (gene encoding SERCA2) have not been reported in the literature.
Two reports have demonstrated immunohistochemical staining of WD with antikeratin antibodies HKN-6 and HKN-7, and this reaction was interpreted as suggesting a follicular origin for WD.
Ultrastructural findings have been interpreted to suggest that acantholysis is due to a defect in desmosome-tonofilament complexes.
Epidermal viral infection with secondary hyperproliferation and acantholysis has also been proposed as a causative mechanism. However, a 2002 study showed that 13 of 13 cases did not show human papillomavirus DNA after polymerase chain reaction testing, and no data support a viral etiology at this time.
Szymanski FJ. Warty dyskeratoma; a benign cutaneous tumor resembling Darier's disease microscopically. Arch Derm. 1957 Apr. 75(4):567-72. [Medline].
Allon I, Buchner A. Warty dyskeratoma/focal acantholytic dyskeratosis--an update on a rare oral lesion. J Oral Pathol Med. Mar 2012. 41(3):261-7. [Medline].
Azuma Y, Matsukawa A. Warty dyskeratoma with multiple lesions. J Dermatol. 1993 Jun. 20(6):374-7. [Medline].
Duray PH, Merino MJ, Axiotis C. Warty dyskeratoma of the vulva. Int J Gynecol Pathol. 1983. 2(3):286-93. [Medline].
Koç M, Kavala M, Kocatürk E, Mete O, Can B, Zindanci I, et al. Multiple warty dyskeratomas on the scalp. Dermatol Online J. 2009 Feb. 15(2):8. [Medline].
Heymann WR. Warty dyskeratoma appearing in a patient with Darier's disease. Int J Dermatol. 1988 Sep. 27(7):521-2. [Medline].
Allon I, Buchner A. Warty dyskeratoma/focal acantholytic dyskeratosis - an update on a rare oral lesion. J Oral Pathol Med. 2011 Sep 21. [Medline].
Savignac M, Edir A, Simon M, Hovnanian A. Darier disease : a disease model of impaired calcium homeostasis in the skin. Biochim Biophys Acta. 2011 May. 1813(5):1111-7. [Medline].
Kaddu S, Dong H, Mayer G, Kerl H, Cerroni L. Warty dyskeratoma--"follicular dyskeratoma": analysis of clinicopathologic features of a distinctive follicular adnexal neoplasm. J Am Acad Dermatol. 2002 Sep. 47(3):423-8. [Medline].
Baran R, Perrin C. Focal subungual warty dyskeratoma. Dermatology. 1997. 195(3):278-80. [Medline].
Cohen PR. Longitudinal erythronychia: individual or multiple linear red bands of the nail plate: a review of clinical features and associated conditions. Am J Clin Dermatol. 2011 Aug 1. 12 (4):217-31. [Medline].
Szymanski FJ. Warty dyskeratoma; a benign cutaneous tumor resembling Darier's disease microscopically. AMA Arch Derm. 1957 Apr. 75(4):567-72. [Medline].